190 related articles for article (PubMed ID: 38683257)
1. Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
Khan I; Kashani-Sabet M
Clin Exp Metastasis; 2024 Apr; ():. PubMed ID: 38683257
[TBL] [Abstract][Full Text] [Related]
2. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
[TBL] [Abstract][Full Text] [Related]
3. New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition.
Zahid H; Buchholz CR; Singh M; Ciccone MF; Chan A; Nithianantham S; Shi K; Aihara H; Fischer M; Schönbrunn E; Dos Santos CO; Landry JW; Pomerantz WCK
J Med Chem; 2021 Sep; 64(18):13902-13917. PubMed ID: 34515477
[TBL] [Abstract][Full Text] [Related]
4. Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.
Zahid H; Olson NM; Pomerantz WCK
Curr Opin Chem Biol; 2021 Aug; 63():57-67. PubMed ID: 33706239
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of NVS-BPTF-1 and evaluation of its biological activity.
Mélin L; Calosing C; Kharenko OA; Hansen HC; Gagnon A
Bioorg Med Chem Lett; 2021 Sep; 47():128208. PubMed ID: 34146702
[TBL] [Abstract][Full Text] [Related]
6. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.
Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK
Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860
[TBL] [Abstract][Full Text] [Related]
7. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new small molecule inhibitors of the BPTF bromodomain.
Liang X; Cao Y; Duan Z; Wang M; Zhang N; Ding Y; Luo C; Lu N; Chen S
Bioorg Chem; 2023 May; 134():106453. PubMed ID: 36898211
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo Experiments.
Martinelli P; Schaaf O; Mantoulidis A; Martin LJ; Fuchs JE; Bader G; Gollner A; Wolkerstorfer B; Rogers C; Balıkçı E; Lipp JJ; Mischerikow N; Doebel S; Gerstberger T; Sommergruber W; Huber KVM; Böttcher J
ChemMedChem; 2023 Mar; 18(6):e202200686. PubMed ID: 36649575
[TBL] [Abstract][Full Text] [Related]
10. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
Bezrookove V; Khan IA; Nosrati M; Miller JR; McAllister S; Dar AA; Kashani-Sabet M
Front Oncol; 2022; 12():1011173. PubMed ID: 36530982
[TBL] [Abstract][Full Text] [Related]
11. Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor.
Tyutyunyk-Massey L; Sun Y; Dao N; Ngo H; Dammalapati M; Vaidyanathan A; Singh M; Haqqani S; Haueis J; Finnegan R; Deng X; Kirberger SE; Bos PD; Bandyopadhyay D; Pomerantz WCK; Pommier Y; Gewirtz DA; Landry JW
Mol Cancer Res; 2021 Aug; 19(8):1338-1349. PubMed ID: 33811160
[TBL] [Abstract][Full Text] [Related]
12. Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening.
Zhang D; Han J; Lu W; Lian F; Wang J; Lu T; Tao H; Xiao S; Zhang F; Liu YC; Liu R; Zhang N; Jiang H; Chen K; Zhao C; Luo C
Bioorg Chem; 2019 May; 86():494-500. PubMed ID: 30780018
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
Dar AA; Bezrookove V; Nosrati M; Ice R; Patino JM; Vaquero EM; Parrett B; Leong SP; Kim KB; Debs RJ; Soroceanu L; Miller JR; Desprez PY; Cleaver JE; Salomonis N; McAllister S; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206824119. PubMed ID: 35969744
[TBL] [Abstract][Full Text] [Related]
14. BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity.
Mayes K; Alkhatib SG; Peterson K; Alhazmi A; Song C; Chan V; Blevins T; Roberts M; Dumur CI; Wang XY; Landry JW
Cancer Res; 2016 Nov; 76(21):6183-6192. PubMed ID: 27651309
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.
Li H; Ilin S; Wang W; Duncan EM; Wysocka J; Allis CD; Patel DJ
Nature; 2006 Jul; 442(7098):91-5. PubMed ID: 16728978
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
[TBL] [Abstract][Full Text] [Related]
17. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
18. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.
Landry J; Sharov AA; Piao Y; Sharova LV; Xiao H; Southon E; Matta J; Tessarollo L; Zhang YE; Ko MS; Kuehn MR; Yamaguchi TP; Wu C
PLoS Genet; 2008 Oct; 4(10):e1000241. PubMed ID: 18974875
[TBL] [Abstract][Full Text] [Related]
19. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
20. BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma.
Jiang C; Yang Y; He S; Yue Z; Xing T; Chu P; Yang W; Chen H; Zhao X; Yu Y; Zhang X; Su Y; Guo Y; Ma X
Biol Proced Online; 2023 May; 25(1):11. PubMed ID: 37170211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
